OverviewSuggest Edit
Mednax is a national medical group that comprises the broad physician services of Pediatrix Medical Group and American Anesthesiology. The Pediatrix Medical Group and American Anesthesiology units, through their affiliated professional corporations, provide physician services including neonatology, maternal-fetal medicine, pediatric cardiology, pediatric intensive care, pediatric and OBGYN hospitalist services and anesthesiology. The Company's physician-led health care organization partners with hospitals, health systems and health care facilities to offer clinical services spanning the continuum of care, as well as revenue cycle management, patient engagement and performance improvement consulting solutions.
| Type | Public | |
| Founded | 1979 | |
| HQ | Fort Lauderdale, US | Map |
| Website | mednax.com | |
| Employee Ratings | More |
Mednax Office Locations
Mednax has an office in Fort Lauderdale
Fort Lauderdale, US (HQ)
1301 Concord Terrace
Mednax Financials and Metrics
Mednax Revenue
Mednax's revenue was reported to be $3.51 b in FY, 2019
| USD | |
|---|---|
Revenue (Q2, 2020) | 509.2m |
Net income (Q2, 2020) | (672.4m) |
EBIT (Q2, 2020) | 34.9m |
Market capitalization (16-Oct-2020) | 1.3b |
Closing stock price (16-Oct-2020) | 14.9 |
Cash (30-Jun-2020) | 132.2m |
EV | 1.2b |
Mednax's current market capitalization is $1.3 b.
- Source: SEC Filings
Annual
| USD | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.7b | 2.0b | 2.2b | 2.6b | 2.9b | 3.3b | 3.6b | 3.5b | ||
Revenue growth, % | 13% | 14% | 15% | |||||||
General and administrative expense | 154.3m | 170.4m | 193.5m | 218.2m | 247.5m | 305.9m | 372.6m | 417.1m | 432.4m | 404.6m |
Operating expense total | 154.3m | 170.4m | 193.5m | 218.2m | 247.5m | 305.9m | 372.6m | 417.1m | 432.4m | 500.0m |
Quarterly
| USD | Q2, 2010 | Q3, 2010 | Q1, 2011 | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 426.7m | 571.3m | 643.7m | 851.2m | 868.3m | 888.7m | 845.9m | 509.2m | |||||||||||||||||||||||
General and administrative expense | 39.2m | 37.5m | 41.8m | 42.7m | 43.0m | 46.9m | 48.2m | 48.2m | 53.3m | 54.6m | 54.7m | 58.4m | 60.8m | 60.6m | 67.9m | 72.4m | 80.2m | 90.0m | 92.1m | 93.5m | 103.8m | 103.0m | 101.4m | 108.8m | 107.9m | 102.9m | 101.8m | 103.5m | 102.4m | 105.2m | 77.7m |
Operating expense total | 39.2m | 37.5m | 41.8m | 42.7m | 43.0m | 46.9m | 48.2m | 48.2m | 53.3m | 54.6m | 54.7m | 58.4m | 60.8m | 60.6m | 67.9m | 72.4m | 80.2m | 90.0m | 92.1m | 93.5m | 103.8m | 103.0m | 101.4m | 108.8m | 107.9m | 102.9m | 105.4m | 131.0m | 122.3m | 105.2m | 77.7m |
Depreciation and amortization | 10.5m | 10.4m | 10.4m | 11.4m | 13.6m | 15.5m | 16.9m | 19.6m | 20.2m | 24.2m | 25.6m | 25.7m | 25.1m | 26.2m | 26.5m | 28.7m | 20.0m | 19.8m | 19.6m | 18.7m | 14.4m |
- Source: SEC Filings
Annual
| USD | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash | 26.3m | 18.6m | 21.3m | 31.1m | 47.9m | 51.6m | 55.7m | 60.2m | 36.7m | 112.8m |
Accounts Receivable | 181.4m | 230.4m | 248.1m | 285.4m | 352.2m | 444.7m | 495.3m | 504.0m | 542.3m | 498.9m |
Prepaid Expenses | 5.2m | 6.3m | 4.9m | 6.4m | 7.0m | 9.6m | 15.6m | 18.8m | 21.9m | |
Current Assets | 296.0m | 337.3m | 359.0m | 408.8m | 467.1m | 527.8m | 587.1m | 627.2m | 657.4m | 731.5m |
Quarterly
| USD | Q2, 2010 | Q3, 2010 | Q1, 2011 | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 26.1m | 61.4m | 15.0m | 24.0m | 35.7m | 22.4m | 12.1m | 66.1m | 34.4m | 13.2m | 16.2m | 19.8m | 17.7m | 71.8m | 50.2m | 65.3m | 60.9m | 55.5m | 51.9m | 52.8m | 41.8m | 40.4m | 48.4m | 40.9m | 38.1m | 34.5m | 26.5m | 24.5m | 28.9m | 312.2m | 132.2m |
Accounts Receivable | 179.0m | 174.7m | 188.2m | 194.0m | 207.1m | 236.7m | 240.9m | 250.5m | 263.8m | 269.8m | 272.8m | 315.7m | 327.4m | 345.2m | 360.9m | 380.5m | 406.8m | 465.8m | 461.2m | 487.0m | 487.7m | 480.4m | 520.0m | 542.6m | 528.0m | 522.8m | 522.6m | 504.2m | 494.7m | 477.0m | 345.7m |
Prepaid Expenses | 5.6m | 5.1m | 4.7m | 5.3m | 8.9m | 5.0m | 7.8m | 5.1m | 4.0m | 7.1m | 6.1m | 4.6m | 7.7m | 8.8m | 4.5m | 9.3m | 10.0m | 8.3m | 11.5m | 13.2m | 9.8m | 12.3m | 13.3m | 11.7m | 15.8m | 17.8m | 12.9m | 14.8m | 20.9m | 19.4m | 14.3m |
Current Assets | 298.8m | 334.0m | 292.2m | 305.3m | 334.0m | 361.3m | 340.2m | 402.8m | 394.6m | 367.7m | 373.0m | 396.0m | 407.7m | 481.1m | 478.0m | 525.5m | 573.2m | 551.4m | 548.5m | 575.5m | 562.4m | 557.6m | 653.3m | 622.7m | 624.9m | 625.4m | 1.1b | 985.5m | 965.3m | 940.9m | 688.3m |
- Source: SEC Filings
Annual
| USD | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 202.7m | 218.0m | 240.9m | 280.5m | 317.2m | 335.7m | 324.6m | 320.4m | 268.6m | (1.5b) |
Depreciation and Amortization | 22.0m | 25.3m | 30.8m | 40.0m | 46.0m | 64.2m | 89.3m | 102.9m | 111.3m | 78.9m |
Accounts Payable | (37.0m) | 21.5m | 17.0m | 49.2m | 66.0m | (7.9m) | 11.6m | 24.6m | 15.4m | 104.2m |
Cash From Operating Activities | 240.6m | 271.0m | 325.7m | 405.4m | 422.6m | 368.7m | 443.8m | 511.4m | 289.9m | 346.6m |
Quarterly
- Source: SEC Filings
| USD | Q2, 2010 |
|---|---|
Financial Leverage | 1.4 x |
Mednax Cybersecurity Score
Mednax Revenue Breakdown
Mednax revenue breakdown by business segment: 39.8% from Neonatology and other pediatric subspecialties, 39.8% from Management services, 8.2% from Anesthesiology, 6.1% from Radiology, 5.1% from Pediatric cardiology and 1.0% from Other
Mednax Online and Social Media Presence
1.29k Twitter followers
Mednax has 1.29k Twitter Followers. The number of followers has increased 0.5% month over month and increased 1% quarter over quarter
Mednax's Trends
Twitter Engagement Stats for @MEDNAX
7.1k
Tweets
896
Following
1.3k
Followers
32
Tweets last 30 days
0.9
Avg. likes per Tweet
71.9%
Tweets with engagement
Mednax News and Updates
September 10, 2020
Mednax to sell radiology business to doctor-owned Radiology Partners for $885 million in cash
Mednax Inc. said Thursday it has reached an agreement to sell its radiology business to physician-owned Radiology Partners for $885 million in cash. Mednax is a provider of maternal-fetal, newborn and pediatric subspecialty care based in Fort Lauderdale, Florida. "This transaction will enable MEDNA…
December 10, 2019
Starboard picks stake in Mednax, calls for co's sale - WSJ
Activist investor Starboard Value LP is
pushing healthcare service provider Mednax Inc to sell
all or part of itself, reported the Wall Street Journal citing
people familiar with the matter.
September 14, 2018
MD LOSS NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Mednax, Inc.; Important Deadline - MD
NEW YORK, Sept. 13, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Mednax, Inc. (NYSE: MD) from February 4, 2016 through July 27, 2017, inclusive (the "Class Period"). The...
September 12, 2018
Lifshitz & Miller LLP Announces Investigation of American Express Company, GDS Holdings Limited, Lannett Company, Inc., Mednax, Inc., Menlo Therapeutics Inc., Papa John's International, Inc., Tetraphase Pharmaceuticals, Inc. and Zion Oil & Gas, Inc.
NEW YORK, Sept. 12, 2018 /PRNewswire/ -- American Express Company (AXP) Lifshitz & Miller announces investigation into possible securities laws violations in connection with the FBI probing pricing practices within AXP's foreign-exchange unit. If you are an AXP investor, and would like...
July 25, 2018
global Ambulatory Surgery Center market iswill reach 113200 million US$ by 2025
QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience Posted via Industr…
January 17, 2018
Global Ambulatory Surgery Center Market 2017: Key Players – EHH, THC, Mednax, QHC, ASCOA, Nueterra Healthcare
WiseGuyReports.com adds “Ambulatory Surgery Centers Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” Posted via Industry Today. Follow us on Twitter @IndustryToday
Mednax Blogs
September 22, 2020
Celebrating Women in Medicine Month
Each September, the American Medical Association’s (AMA) Women Physicians Section celebrates Women in Medicine Month to showcase the accomplishments of women physicians and highlight advocacy related to female physicians and health issues impacting women.
September 17, 2020
Patient Safety for the OB Hospitalist: Improving Outcomes for Expecting Moms
World Patient Safety Day is observed annually on Sept. 17. MEDNAX has numerous quality and safety initiatives covering many specialty areas of care. For Jean Moon, M.D., and Kathleen Horowitz, M.D., patient safety is something they practice daily as obstetric (OB) hospitalists for the Ob…
September 16, 2020
Why is newborn screening important?
September commemorates Newborn Screening Awareness Month, a time to educate and raise awareness for newborn screenings. We sat down with experts across our practices to answer questions about the various newborn screening tests.
September 14, 2020
Neonatal nurse practitioners focus on the most important thing: their newborn
What is essential in health care? The answer depends on who you ask. To Brenda Griner, APRN, MSN, MHA, critical thinking when treating the sickest of babies is imperative. When Brenda was a staff nurse at Broward Health over 30 years ago, she was first introduced to the role of the Neona…
September 08, 2020
Quality clinical research leads to quality care
Research plays a key part in moving health care forward. MEDNAX established the Center for Research, Education, Quality and Safety (CREQS) to further the company’s mission to take great care of the patient, every day and in every way. Each year, our clinicians participate in and publish …
September 03, 2020
Improving outcomes for patients with placenta accreta
In 2012, Phoenix Perinatal Associates, a Maternal-Fetal Medicine team at Banner University Medical Center in Phoenix, AZ, implemented a new program that would profoundly impact outcomes for their patients. The program focuses on placenta accreta spectrum disorders, a condition occurring …
Mednax Frequently Asked Questions
When was Mednax founded?
Mednax was founded in 1979.
How many employees does Mednax have?
Mednax has 13,805 employees.
What is Mednax revenue?
Latest Mednax annual revenue is $3.5 b.
What is Mednax revenue per employee?
Latest Mednax revenue per employee is $254.5 k.
Who are Mednax competitors?
Competitors of Mednax include Tenet Healthcare, LifePoint Health and Envision Healthcare.
Where is Mednax headquarters?
Mednax headquarters is located at 1301 Concord Terrace, Fort Lauderdale.
Where are Mednax offices?
Mednax has an office in Fort Lauderdale.
How many offices does Mednax have?
Mednax has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies